Skip to main content

Table 2 Baseline characteristics of the female and male elderly MPM patients

From: Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly

Variable Male
N = 391 (58.80%)
Female
N = 274 (41.20%)
P value
Age at diagnosis 73.68 ± 6.21 75.28 ± 7.06 0.002
Race    0.083
White 369 (94.37%) 247 (90.15%)  
Black 10 (2.56%) 14 (5.11%)  
Asian or Pacific Islander 12 (3.07%) 11 (4.01%)  
American Indian/Alaska Native 0 2 (0.73%)  
Insurance status    0.838
Insured 137 (35.04%) 102 (37.23%)  
Uninsured 2 (0.51%) 1 (0.36%)  
Unknown 252 (64.45%) 171 (62.41%)  
Marital status     < 0.001
Married 287 (73.40%) 111 (40.51%)  
Unmarried 99 (25.32%) 157 (57.30)  
Unknown 5 (1.28%) 6 (2.19%)  
Site    0.878
Peritoneum 369 (94.37%) 261 (95.26%)  
Retroperitoneum 20 (5.12%) 12 (4.38%)  
Ovarlapping lesion of retroperitoneum and peritoneum 2 (0.51%) 1 (0.36%)  
Histology    0.531
Epithelioid 116 (29.67%) 79 (28.83%)  
Biphasic 11 (2.81%) 8 (2.92%)  
Sarcomatoid 8 (2.05%) 11 (4.01%)  
Unknown 256 (65.47%) 176 (64.23%)  
Grade    0.274
Well differentiated 14 (3.58%) 19 (6.93%)  
Moderately differentiated 7 (1.79%) 4 (1.46%)  
Poorly differentiated 27 (6.91%) 21 (7.66%)  
Undifferentiated 5 (1.28%) 6 (2.19%)  
Unknown 338 (86.44%) 224 (81.76%)  
Stage    0.190
Localized 32 (8.18%) 36 (13.14%)  
Regional 58 (14.83%) 37 (13.50%)  
Distant 251 (64.19%) 163 (59.49%)  
Unknown 50 (12.79) 38 (19.87%)  
Surgery     < 0.001
Cancer-directed surgery done 100 (25.58%) 122 (44.53%)  
No cancer-directed surgery 284 (72.63%) 146 (53.28%)  
Radiotherapy    0.605
Yes 10 (2.56%) 5 (1.82%)  
No/unknown 381 (97.44%) 269 (98.18%)  
Chemotherapy    0.342
Yes 178 (45.78%) 115 (42.97%)  
No/unknown 212 (54.22%) 159 (58.03%)  
  1. Significant P values shown in bold
  2. MPM, malignant peritoneal mesothelioma